Labcorp Holdings Inc's stock surged 9.80% in pre-market trading following the release of its first-quarter 2026 financial results that exceeded analyst expectations and an upward revision of its full-year outlook.
The company reported adjusted earnings per share of $4.25 for Q1 2026, beating consensus estimates of approximately $4.09 to $4.11 and representing a 10.6% increase from the same period last year. Revenue rose 5.8% year-over-year to $3.54 billion, also surpassing analyst forecasts of around $3.50 to $3.51 billion.
Labcorp raised its full-year 2026 guidance, now expecting adjusted EPS in the range of $17.70 to $18.35 and revenue between $14.65 billion and $14.80 billion. The company cited organic growth, continued momentum across its Diagnostics and Central Laboratory businesses, and strategic initiatives including expansion in specialty diagnostics and new collaborations as drivers of its strong performance.
Comments